Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 21Leukemia, Lymphocytic, Chronic, B-Cell 14Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Follicular 9Leukemia, Myeloid, Acute 9Hodgkin Disease 7Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Leukemia 6Myelodysplastic Syndromes 5Multiple Myeloma 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma, B-Cell 5Hematologic Neoplasms 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Burkitt Lymphoma 4Stomach Neoplasms 3Recurrence 3Lymphoma, Large-Cell, Immunoblastic 3Colorectal Neoplasms 3Waldenstrom Macroglobulinemia 2Neoplasms 2Neoplasm Metastasis 2Melanoma 2Leukemia, Myelomonocytic, Juvenile 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1

Interventions

venetoclax 1ixazomib 1Interleukin-2 1Granulocyte-Macrophage Colony-Stimulating Factor 1Antineoplastic Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Amyloidosis × Interleukin-2 × Lymphoid × Clear all
NCT00952237 2018-04-25

Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
13 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Amyloidosis, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡